SG Americas Securities’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,298
Closed -$86K 3484
2025
Q4
$86K Buy
25,298
+3,061
+14% +$14.9K ﹤0.01% 3268
2025
Q3
$151K Buy
22,237
+289
+1% +$2.39K ﹤0.01% 2897
2025
Q2
$299K Buy
21,948
+10,843
+98% +$102K ﹤0.01% 2006
2025
Q1
$60K Sell
11,105
-3,929
-26% -$22.3K ﹤0.01% 3199
2024
Q4
$74K Buy
15,034
+1,755
+13% +$9.2K ﹤0.01% 2825
2024
Q3
$70K Buy
+13,279
New +$76.6K ﹤0.01% 3170

Other funds holding LFMD

SG Americas Securities's LFMD Position: Q1 2026 in Review

SG Americas Securities sold out of LifeMD (LFMD) in Q1 2026, closing a stake of 25,298 shares — an estimated $86K sold.

SG Americas Securities first reported a position in LFMD in Q3 2024 and held it in 6 quarters. The position peaked at $299K in Q2 2025. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.

  • SG Americas Securities reported no remaining LifeMD position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 25,298 LifeMD shares in Q1 2026, an estimated $86K.
  • SG Americas Securities first reported a position in LifeMD in Q3 2024 and held it in 6 quarters.
  • SG Americas Securities's LifeMD position peaked at $299K in Q2 2025.
  • 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.